Literature DB >> 1374056

Involvement of antigen-presenting cells in the enhancement of the in vitro antibody responses by cholera toxin B subunit.

Y Hirabayashi1, S I Tamura, K Shimada, T Kurata.   

Abstract

The enhancing effect of cholera toxin B subunit (CTB) on primary antibody responses to keyhole limpet haemocyanin (KLH) and the cellular basis of the effect were investigated, using in vitro cultures of mouse spleen cells. CTB (1-100 ng/ml) enhanced anti-KLH IgM, IgG and IgA antibody responses in a dose-dependent manner, when added to the cultures with KLH. This immunoenhancement was antigen specific, but not due to either polyclonal activation of the spleen cells or antigenic cross-reactivity between CTB and KLH. CTB did not affect the kinetics of the anti-KLH antibody responses. Early (Days 0-1) addition of CTB to the cultures enhanced the anti-KLH antibody production, whereas late (Days 5-7) addition of CTB did not. Addition of CTB with KLH to splenic adherent cells (SAC) resulted in a dose-dependent enhancement of the anti-KLH antibody responses, when the SAC were reconstituted with unimmunized non-adherent cells. Moreover, CTB enhanced IL-1 secretion from SAC incubated with KLH. These results suggest that CTB enhances the primary anti-KLH antibody responses in vitro by acting on early events in the responses, and that antigen-presenting cells play a major role in the enhancement.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374056      PMCID: PMC1384745     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Mucosal priming of T-lymphocyte responses to fed protein antigens using cholera toxin as an adjuvant.

Authors:  C J Clarke; A D Wilson; N A Williams; C R Stokes
Journal:  Immunology       Date:  1991-03       Impact factor: 7.397

2.  Regulation of the in vitro early anamnestic antibody response by exogenous cholera enterotoxin and cyclic AMP.

Authors:  R G Cook; A B Stavitsky; M D Schoenberg
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

3.  Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro.

Authors:  A Bromander; J Holmgren; N Lycke
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

4.  Cellular and genetic control of antibody responses in vitro. I. Cellular requirements for the generation of genetically controlled primary IgM responses to soluble antigens.

Authors:  R J Hodes; A Singer
Journal:  Eur J Immunol       Date:  1977-12       Impact factor: 5.532

5.  Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.

Authors:  C O Elson; W Ealding
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

Review 6.  Actions of cholera toxin and the prevention and treatment of cholera.

Authors:  J Holmgren
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

7.  Augmentation of the in vitro humoral immune response by pharmacologic agents. I: An explanation for the differential enhancement of humoral immunity via agents that elevate cAMP.

Authors:  S W Burchiel; K L Melmon
Journal:  Immunopharmacology       Date:  1979-03

8.  Pretreatment of plastic Petri dishes with fetal calf serum. A simple method for macrophage isolation.

Authors:  K Kumagai; K Itoh; S Hinuma; M Tada
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

9.  A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions.

Authors:  C O Elson; W Ealding; J Lefkowitz
Journal:  J Immunol Methods       Date:  1984-02-24       Impact factor: 2.303

10.  T-Cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation.

Authors:  S Gillis; S B Mizel
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

View more
  3 in total

1.  Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.

Authors:  H Y Wu; M W Russell
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

2.  Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits.

Authors:  E Harokopakis; G Hajishengallis; T E Greenway; M W Russell; S M Michalek
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

3.  Modulation of B-cell activation by the B subunit of Escherichia coli enterotoxin: receptor interaction up-regulates MHC class II, B7, CD40, CD25 and ICAM-1.

Authors:  T O Nashar; T R Hirst; N A Williams
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.